OBJECTIVE: Bipolar disorders have a strong genetic underpinning. Little is known about biological predispositions that convey vulnerability for the illness. We searched for biological vulnerability markers using proton magnetic resonance spectroscopy (MRS) in both affected and unaffected participants at high genetic risk for bipolar disorder. METHODS: We recruited high-risk participants aged 15-30 years from families in which multiple members were affected with bipolar disorder. Our primary sample included 14 affected and 15 unaffected relatives of probands with bipolar I disorder. Our extended sample comprised 19 affected and 21 unaffected participants with a family history of either bipolar I or bipolar II disorders. We matched both samples by age and sex with 31 control participants without a personal or family history of psychiatric disorders. We performed single voxel proton MRS at 1.5 T in bilateral dorsal and ventral medial prefrontal cortices with correction for grey matter proportion. RESULTS: We found comparable levels of choline, creatine, myo-inositol and N-acetylaspartate among the groups in both samples. There were no differences between regions of the medial prefrontal cortex or between hemispheres for any of the metabolites in any of the samples. The exclusion of 5 participants taking medication did not change our results. CONCLUSION: Neurochemical changes in the medial prefrontal cortex that are measurable using proton MRS do not appear to be antecedent to the onset of mood disorders in genetically susceptible individuals.
OBJECTIVE:Bipolar disorders have a strong genetic underpinning. Little is known about biological predispositions that convey vulnerability for the illness. We searched for biological vulnerability markers using proton magnetic resonance spectroscopy (MRS) in both affected and unaffected participants at high genetic risk for bipolar disorder. METHODS: We recruited high-risk participants aged 15-30 years from families in which multiple members were affected with bipolar disorder. Our primary sample included 14 affected and 15 unaffected relatives of probands with bipolar I disorder. Our extended sample comprised 19 affected and 21 unaffected participants with a family history of either bipolar I or bipolar II disorders. We matched both samples by age and sex with 31 control participants without a personal or family history of psychiatric disorders. We performed single voxel proton MRS at 1.5 T in bilateral dorsal and ventral medial prefrontal cortices with correction for grey matter proportion. RESULTS: We found comparable levels of choline, creatine, myo-inositol and N-acetylaspartate among the groups in both samples. There were no differences between regions of the medial prefrontal cortex or between hemispheres for any of the metabolites in any of the samples. The exclusion of 5 participants taking medication did not change our results. CONCLUSION: Neurochemical changes in the medial prefrontal cortex that are measurable using proton MRS do not appear to be antecedent to the onset of mood disorders in genetically susceptible individuals.
Entities:
Keywords:
bipolar disorders; magnetic resonance spectroscopy
Authors: R D Todd; W Reich; T A Petti; P Joshi; J R DePaulo; J Nurnberger; T Reich Journal: J Am Acad Child Adolesc Psychiatry Date: 1996-05 Impact factor: 8.829
Authors: G J Moore; J M Bebchuk; K Hasanat; G Chen; N Seraji-Bozorgzad; I B Wilds; M W Faulk; S Koch; D A Glitz; L Jolkovsky; H K Manji Journal: Biol Psychiatry Date: 2000-07-01 Impact factor: 13.382
Authors: Manon Hj Hillegers; Catrien G Reichart; Marjolein Wals; Frank C Verhulst; Johan Ormel; Willem A Nolen Journal: Bipolar Disord Date: 2005-08 Impact factor: 6.744
Authors: Alessandro Bertolino; Mark Frye; Joseph H Callicott; Venkata S Mattay; Rebecca Rakow; Jennifer Shelton-Repella; Robert Post; Daniel R Weinberger Journal: Biol Psychiatry Date: 2003-05-15 Impact factor: 13.382
Authors: Stephen R Dager; Seth D Friedman; Aimee Parow; Christina Demopulos; Andrew L Stoll; In Kyoon Lyoo; David L Dunner; Perry F Renshaw Journal: Arch Gen Psychiatry Date: 2004-05
Authors: Pablo Davanzo; Kenneth Yue; M Albert Thomas; Thomas Belin; Jim Mintz; T N Venkatraman; Eliana Santoro; Sarah Barnett; James McCracken Journal: Am J Psychiatry Date: 2003-08 Impact factor: 18.112
Authors: Mark A Frye; M Albert Thomas; Kenneth Yue; Nader Binesh; Pablo Davanzo; Joseph Ventura; Joseph O'Neill; Barry Guze; John G Curran; Jim Mintz Journal: Psychiatry Res Date: 2007-03-07 Impact factor: 3.222
Authors: Manpreet K Singh; Booil Jo; Nancy E Adleman; Meghan Howe; Layla Bararpour; Ryan G Kelley; Daniel Spielman; Kiki D Chang Journal: Psychiatry Res Date: 2013-09-09 Impact factor: 3.222
Authors: Nina Vanessa Kraguljac; Meredith Reid; David White; Rebecca Jones; Jan den Hollander; Deborah Lowman; Adrienne Carol Lahti Journal: Psychiatry Res Date: 2012-09-13 Impact factor: 3.222
Authors: Tomas Hajek; Jeffrey Cullis; Tomas Novak; Miloslav Kopecek; Ryan Blagdon; Lukas Propper; Pavla Stopkova; Anne Duffy; Cyril Hoschl; Rudolf Uher; Tomas Paus; L Trevor Young; Martin Alda Journal: Biol Psychiatry Date: 2012-07-20 Impact factor: 13.382
Authors: Manpreet K Singh; Daniel Spielman; Allison Libby; Elizabeth Adams; Tenah Acquaye; Meghan Howe; Ryan Kelley; Allan Reiss; Kiki D Chang Journal: Bipolar Disord Date: 2011-03 Impact factor: 6.744
Authors: Tomas Hajek; Michael Bauer; Andrea Pfennig; Jeffrey Cullis; Jana Ploch; Claire O'Donovan; Georg Bohner; Randolf Klingebiel; L Trevor Young; Glenda M Macqueen; Martin Alda Journal: J Psychiatry Neurosci Date: 2012-05 Impact factor: 6.186
Authors: Anne Duffy; Tomas Hajek; Martin Alda; Paul Grof; Robert Milin; Glenda MacQueen Journal: Eur Arch Psychiatry Clin Neurosci Date: 2009-04-23 Impact factor: 5.270